Skip to main content

Grafa News and Videos — Page 1060

Grafa Headlines

Latest

Grafa

Medicus Pharma files Abu Dhabi regulatory application for endometriosis trial

Medicus Pharma (NASDAQ:MDCX) submitted an Investigational New Drug (IND) application to the Department of Health, Abu Dhabi, seeking authorization to launch a genomics-enabled Phase 2a clinical trial evaluating its candidate Teverelix in women with symptomatic endometriosis.

Read more: Medicus Pharma files Abu Dhabi regulatory application for endometriosis trial
Grafa

Rafael Holdings climbs on completion of pivotal Phase 3 rare disease trial

Rafael Holdings (NYSE:RFL) reported its third-quarter fiscal 2026 financial results alongside a critical clinical milestone, finalizing the active clinical phase of its lead rare disease program and clearing the path for a regulatory submission later this year.

Read more: Rafael Holdings climbs on completion of pivotal Phase 3 rare disease trial

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift